Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Parathyroid tumour benign
ADR ID BADD_A03307
ADR Hierarchy
05      Endocrine disorders
05.04      Parathyroid gland disorders
05.04.03      Parathyroid disorders NEC
05.04.03.003      Parathyroid tumour benign
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.37      Endocrine neoplasms benign
16.37.02      Endocrine neoplasms benign NEC
16.37.02.002      Parathyroid tumour benign
Description Tumors or cancer of the PARATHYROID GLANDS. [MeSH]
MedDRA Code 10033964
MeSH ID D010282
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Benign neoplasm of parathyroid gland | Parathyroid adenoma | Parathyroid chief cell adenoma | Parathyroid mixed cell type adenoma | Parathyroid transitional clear cell adenoma | Parathyroid tumour benign | Parathyroid tumor benign | Parathyroid Neoplasms | Neoplasm, Parathyroid | Parathyroid Neoplasm | Neoplasms, Parathyroid | Parathyroid Adenoma | Adenoma, Parathyroid | Adenomas, Parathyroid | Parathyroid Adenomas | Parathyroid Carcinoma | Carcinoma, Parathyroid | Carcinomas, Parathyroid | Parathyroid Carcinomas | Cancer of Parathyroid | Parathyroid Cancers | Cancer of the Parathyroid | Parathyroid Cancer | Cancer, Parathyroid | Cancers, Parathyroid
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00066Alendronic acid0.000044%
BADD_D00337Calcitriol0.000335%
BADD_D00979Furosemide0.000028%
BADD_D01250Lasofoxifene--
BADD_D01303Lithium carbonate0.002142%
BADD_D01304Lithium cation0.000960%
BADD_D02331Valsartan0.000053%
BADD_D02434Cinacalcet0.004886%
BADD_D02514Etelcalcetide0.001278%
The 1th Page    1    Total 1 Pages